Update of occupational lung disease.


Journal

Journal of occupational health
ISSN: 1348-9585
Titre abrégé: J Occup Health
Pays: Australia
ID NLM: 9616320

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 03 04 2018
revised: 01 09 2018
accepted: 20 09 2018
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 23 4 2019
Statut: ppublish

Résumé

Occupational Lung Disease is an oldest but still a biggest problem in occupational health. Steering Committee members of the Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group selected and summarized current topics on occupational lung diseases based on expert opinion, as informed by governmental regulation, public health concerns, and frequently discussed in related academic conferences. The topics included in this review are professional education in medical screening skills, 2014 update of Helsinki Criteria, respiratory diseases found in the earthquake and tsunami affected regions, newly recognized occupational lung diseases, and potential respiratory health hazards. Although occupational lung diseases seem to stay as one of the major concerns in occupational health, screening tools and control measures are standardized for the better prevention of the diseases. As this health problem usually occurs in where the most actively economically developing area is, the patients tend to increase in emerging economic powers with huge population.

Identifiants

pubmed: 30698346
doi: 10.1002/1348-9585.12031
pmc: PMC6499361
doi:

Substances chimiques

Iridium 44448S9773

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-18

Subventions

Organisme : Japan Society for Occupational Health

Informations de copyright

© 2019 The Authors. Journal of Occupational Health published by John Wiley & Sons Australia, Ltd on behalf of The Japan Society for Occupational Health.

Références

J Occup Health. 2009;51(6):513-21
pubmed: 19834281
Risk Anal. 2015 Oct;35(10):1940-56
pubmed: 25943334
J Occup Health. 2009;51(3):210-22
pubmed: 19372629
J Anesth. 2012 Apr;26(2):246-9
pubmed: 22057370
Ind Health. 2012;50(2):84-94
pubmed: 22301987
Part Fibre Toxicol. 2014 Jan 09;11:3
pubmed: 24405760
Part Fibre Toxicol. 2016 Oct 13;13(1):53
pubmed: 27737701
J Occup Health. 2019 Jan;61(1):10-18
pubmed: 30698346
Scand J Work Environ Health. 1997 Aug;23(4):311-6
pubmed: 9322824
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
N Engl J Med. 2005 Jun 23;352(25):2628-36
pubmed: 15972870
J Med Case Rep. 2011 Oct 25;5:526
pubmed: 22027347
Spine (Phila Pa 1976). 2014 May 20;39(12):E739-42
pubmed: 24718064
Respir Investig. 2013 Mar;51(1):17-23
pubmed: 23561254
Am J Respir Crit Care Med. 2004 Sep 15;170(6):691-715
pubmed: 15355871
Thorax. 2015 Nov;70(11):1040-6
pubmed: 26286723
J Occup Health. 2012;54(2):103-11
pubmed: 22322108
Am J Public Health. 1986 Mar;76(3 Suppl):59-65
pubmed: 3080911
Lancet Oncol. 2017 May;18(5):581-582
pubmed: 28408286
Toxicol Lett. 2017 Jan 4;265:61-69
pubmed: 27865850
Western Pac Surveill Response J. 2012 Oct 30;3(4):67-70
pubmed: 23908944
Lancet. 1998 Apr 25;351(9111):1242-5
pubmed: 9643744
Inhal Toxicol. 2009 Jul;21 Suppl 1:55-60
pubmed: 19558234
Med J Aust. 2005 Apr 4;182(7):364
pubmed: 15804231
Nanotoxicology. 2014 Dec;8(8):885-93
pubmed: 24040866
Epidemiol Prev. 1995 Jun;19(63):226-7
pubmed: 7641866
Am J Ind Med. 2015 Jan;58(1):61-8
pubmed: 25345911
Int J Cardiol. 2008 Sep 16;129(1):152-4
pubmed: 17651831
J UOEH. 2017;39(2):123-132
pubmed: 28626123
J Occup Health. 2007 Jul;49(4):328-44
pubmed: 17708058
Am J Respir Crit Care Med. 2013 Jan 1;187(1):110-1
pubmed: 23281355
Intern Med. 2017;56(4):409-412
pubmed: 28202862
Ind Health. 2012;50(2):142-6
pubmed: 22498728
Am J Respir Crit Care Med. 2013 Jul 1;188(1):90-6
pubmed: 23590275
Intern Med. 2016;55(24):3645-3653
pubmed: 27980267
Lancet. 1999 Jul 10;354(9173):99-105
pubmed: 10408484
Intern Med. 2011;50(19):2233-6
pubmed: 21963747
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
Tohoku J Exp Med. 2011;223(4):305-7
pubmed: 21478655
BMJ Open. 2013 Jan 03;3(1):
pubmed: 23293238
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
Chest. 2014 Nov;146(5):1166-1175
pubmed: 24946105
Inhal Toxicol. 2009 Aug;21(10):812-8
pubmed: 19225964
Respir Investig. 2012 Dec;50(4):124-8
pubmed: 23199975
Respir Care. 2012 Oct;57(10):1674-8
pubmed: 22417634
Respir Investig. 2013 Dec;51(4):207-11
pubmed: 24238227
Ann Vasc Dis. 2014;7(4):365-8
pubmed: 25593620
JAMA. 1981 Dec 4;246(22):2585-9
pubmed: 7029020
Scand J Work Environ Health. 2015 Jan;41(1):5-15
pubmed: 25299403
Scand J Work Environ Health. 2000 Oct;26(5):449-54
pubmed: 11103845
Circ J. 2013;77(2):490-3
pubmed: 23328448

Auteurs

Narufumi Suganuma (N)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
Department of Environmental Medicine, Kochi Medical School, Kochi Univeristy, Nankoku, Japan.

Yuji Natori (Y)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
Hirano-Kameido Himawari-Clinic, Koto-ku, Japan.

Hajime Kurosawa (H)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
Department of Occupational Health, Tohoku University School of Medicine, Sendai, Japan.

Makiko Nakano (M)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Shinjuku, Japan.

Takahiko Kasai (T)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
Department of Pathology, Kinki-Chuo Chest Medical Center, Sakai, Japan.

Yasuo Morimoto (Y)

Japan Society for Occupational Health (JSOH) Occupational Lung Disease Study Group, Tokya, Japan.
University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH